Document is current
Any future updates will be listed below
-
Authors
Kyereh, Felix Kwaku https://orcid.org/0009-0005-4364-330X
Ohemeng, Agartha N. https://orcid.org/0000-0002-7986-1350
Engle-Stone, Reina https://orcid.org/0000-0003-2446-6166
Wessells, K. Ryan
Kumordzie, Sika M.
Arnold, Charles D. https://orcid.org/0000-0001-6510-3172
Davis, Jennie N.
Becher, Emily R.
Fuseini, Ahmed D.
Nyaaba, Kania W.
Tan, Xiuping
Vosti, Stephen A.
Adu-Afarwuah, Seth
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 29 December 2025
First Online: 7 January 2026
Declarations
:
: Ethical approval for this study was obtained from the Ghana Health Service Ethical Review Committee (GHSERC ID: 024/11/21), the Institutional Review Board at the University of California, Davis (IRB ID: 1837253), and the Ghana Food and Drugs Authority (Certificate No. FDA/CT/2213 [ ]). The trial was registered at ClinicalTrials.gov (NCT05178407) and the Pan-African Clinical Trials Registry (PACTR202206868437931). Written informed consent was obtained from all participants prior to their involvement in the study. For participants under 18 years of age, assent was obtained in addition to parental or caregiver consent. All procedures were conducted in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
